It was reported that LCN2 activates cAMP-mediated signaling in bone cells, while increased cAMP signaling may inhibit osteoblast differentiation by decreasing BMP pathway signaling [41, 42], which indicates the negative effect of cancer-derived LCN2 on osteogenesis. This evidence concerns the gene LCN2 and cancer.